Clay Siegal-Shaping Today’s World of Medicine
Clay Siegal is the co-founder and President of Seattle Genetics, a company that develops FDA-approved antibody-drug conjugates to offer a lasting cure to patients with a variety of conditions. Clay is a scientist by profession with a specialization in cancer therapies. His firm is founded on a scientific foundation, drug development techniques, and rigorous research. After obtaining FDA approval to engage in the development of the antibody-drug conjugates, he developed his first product and later partnered with Takeda Pharmaceutical Limited to develop ADCETRIS, of which has already become a worldwide brand. His global product is currently selling in over 65 nations worldwide. Seattle Genetics is on the verge of developing a variety of drugs for cancer treatment.
Before co-founding his firm, Clay Siegal worked with PRI(Pharmaceutical Research Institute) and National Cancer Institute. Moreover, Clay has worked with global pharmaceutical brands like Ultragenyx Pharmaceutical. Clay’s dedicated contribution to modern medicine hasn’t gone into waste, for he has been awarded severally with multiple awards, key among them being the Pacific Northwest Award.
Clay Siegal got the idea of starting Seattle Genetics after watching his ailing father succumb to cancer. At the time, there were barely any tools and drugs to curb the deadly ailment. Even before joining George Washington University to pursue his doctorate, he had already thought of helping cancer patients. His goal is solely to ensure cancer patients get the best and safest drugs to cure the ailment. With each day, Clay is slowly getting closer to his dream. As an entrepreneur, Clay Siegal recommends everyone to learn and keep learning as much as they can. Most importantly, Clay urges everyone to associate with intelligent and smart people. As a shrewd and reputable investor not just in Seattle but throughout the nation, Clay advises investors to work closely with others who are dealing with businesses within their field.
On top of having a doctorate in genetics, Clay Siegal also earned a degree in Zoology having studied at Maryland University. In addition, he is an active board member of various pharmaceutical boards throughout the nation. Moreover, Clay is a respected author, with over 70 publications already under his belt.